liquid biopsy clinical development

Hawkeye Bio is a privately held biotechnology company founded in 2019 and based in Los Angeles and Ireland. It advances early cancer detection through blood-based testing using a proprietary graphene biosensor platform that measures protease activity. Its first product, LEAP (Lung Enzyme Activity Profile), is a prescription blood test for early lung cancer detection that complements low-dose CT screening. LEAP testing is performed by HealthQuest Esoterics' CLIA-certified laboratory in Irvine, California.

Read more

blood-based testinggraphene biosensor platformprotease activity measurement